Principal and Managing Partner, Raaha LLC

Doctor of Philosophy, University of Missouri-Columbia

Dr. Aloka Srinivasan has 31 years of experience in Pharmaceuticals and Drug Safety. She earned her BS in Chemistry from Presidency University, her MS in Chemistry from the University of Calcutta, and her Ph.D. in Organic Chemistry from the University of Missouri-Columbia. Formerly, this expert served as a Team Leader at the U.S. Food and Drug Administration, as a Principal Consultant at Parexel, and as the Vice President of Global Regulatory Practice at Lachman Consultants. Currently, this expert is the Principal and Managing Partner of Raaha LLC.

a*********@r*****.com

(703) ***-****

Herndon, Virginia

$499

Special offer

Get a FREE Demo of Dr. Aloka Srinivasan, PhD's Radar Profile

Review this expert's litigation history, supporting legal docs, publications, professional background, and more.

LIVE DEMO

Get a FREE Demo of Dr. Aloka Srinivasan, PhD's Radar Profile

Radar Metrics At A Glance

Expert Witness Activity

lock icon

Plaintiff Cases

lock icon

Defense Cases

lock icon

Expert Challenges

lock icon

Deposition Transcripts

lock icon

Publications

28

Media & News

80

Social Media Mentions

134

Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.

Expert Witness Activity

Case Name

Role

Filed Date

In re: Master Case for Zantac Cases

Expert Witness

2023-04-27

Radar monitors both national and state court systems to track litigation activity and access court documents.

View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.

image

Litigation Analytics

Retained By

Defense

Plaintiff

33%67%

Activity over time

0

25

50

75

100

2000

0

2002

0

2004

0

2006

0

2008

0

2010

0

Activity by state

Map of USA

Case Outcome

0

25

50

75

100

Publications

Radar found 28 records

Title

Type

Complex Generics: Maximizing FDA Approval Process

Magazine/Trade Publication

A study of putative intermediates involved in the activation of beta-oxidized nitrosamines and nitrosation of N-substituted aziridine

Research Paper

N-Nitrosoaziridinium Ion Isomerization: Dihydrodiazete N-Oxides and Azoxyalkenes from Aziridine Nitrosation

Journal Article

Radar monitors a wide array of publication sources, including links to abstracts.

Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.

image

Media & News

Radar found 80 records

Title

Description

AAM's GRx+Biosims "Nitrosamines In Pharmaceuticals

The presenters included representatives from the Agency and the Industry, and the moderator was Aloka Srinivasan @ASrinivasan . The presentations were ...

🇪🇺 EMA Q&A Rev. 16 EMA/409815/2020 - MAJOR ...

Jul 7, 2023 ----- Nitrosamides Should They Be Treated the Same as Nitrosamines Published on: October 15, 2022. Aloka Srinivasan , Chuck Lambert. Pharmaceutical ...

Summary of the FDA, UMD Meeting on June 15, 2023, ...

Jun 15, 2023 ----- Aloka Srinivasan , Ph.D. Principal and Managing Partner Session 1: Risk of Forming NDSRIs and Strategies to Mitigate the Risk Session 2: ...

Radar scours thousands of media and news sources across the internet 24/7.

Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.

image

Depositions & Transcripts

Radar finds deposition and trial transcripts, and uses OCR to convert each document into fully searchable text.

Explore deposition/trial transcripts, expert CVs, reports, affidavits, court exhibits, filings, and more.

image

Education

Institution

Degree Type

University of Missouri-Columbia

Doctor of Philosophy

University of Calcutta

Master of Science

Presidency University Kolkata

Bachelor of Science

Work History

Title

Employer

Principal and Managing Partner

Raaha LLC

Vice President

Lachman Consultants

Vice President

Lupin Pharmaceuticals, Inc.

What to expect from a Radar profile

Access detailed litigation history and performance metrics.

Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.

Delivered in 3–5 days

Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.

24/7 monitoring for 12 months

Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.

bakground
Expert iQ logo
Expert Radar features